Proxy Form for the Extraordinary General Meeting to be held on Wednesday, December 9, 2026
Filed with HKEX · Stock code 1541 · · 1 page · English
Summary by 6ix AI
This filing is a proxy form for an extraordinary general meeting of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. The meeting is scheduled to consider several resolutions, including the appointment of a new independent director and changes to the company's auditor. Shareholders are invited to appoint a proxy to vote on their behalf at the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
ImmuneOnco Biopharmaceuticals (Shanghai) Inc on 6ix
Earlier from ImmuneOnco Biopharmaceuticals (Shanghai)
- (1) Appointment of independent non-executive director; (2) proposed removal of auditor; (3) proposed appointment of auditor; and (4) notice of extraordinary general meeting
- Notice of the extraordinary general meeting
- Next Day Disclosure Return
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October, 2026
- Proposed change of auditor
Follow ImmuneOnco Biopharmaceuticals (Shanghai) into a list and get an email when it puts out news.
Follow ImmuneOnco Biopharmaceuticals (Shanghai)